Cargando…

185 Anaphylaxis after Anesthetic Reversal

BACKGROUND: Sugammadex is a new drug used for the reversal of neuromuscular blockade by rocuronium or vecuronium, a muscle relaxant used as fast acting. METHODS: We performed a review of a case of a patient scheduled for osteosynthesis of the ankle with a history of bronchial asthma and sensitizatio...

Descripción completa

Detalles Bibliográficos
Autor principal: Chugo, Sendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512709/
http://dx.doi.org/10.1097/01.WOX.0000411942.20977.e1
_version_ 1782251783638220800
author Chugo, Sendy
author_facet Chugo, Sendy
author_sort Chugo, Sendy
collection PubMed
description BACKGROUND: Sugammadex is a new drug used for the reversal of neuromuscular blockade by rocuronium or vecuronium, a muscle relaxant used as fast acting. METHODS: We performed a review of a case of a patient scheduled for osteosynthesis of the ankle with a history of bronchial asthma and sensitization to Dermatophagoides pteronyssinus. After the surgery the patient suffered anaphylaxis, a minute after the use of sugammadex. RESULTS: We evaluated the drugs used during anesthesia Prick and intradermal, and we obtained positive results with Sugammadex at 1 month, 3 and 6 months. We performed the basophil activation test giving a positive result. Tests show IgE-mediated sensitization with positive skin tests and basophil activation test. CONCLUSIONS: It is believed that prior sensitization may have occurred due to ingestion of cyclodextrins which is present in many foods. The atopic status of this patient may have had some awareness of cyclodextrins. This case has been published as the first documented case of anaphylaxis by sugammadex with normal doses. Our case raises clear that the underlying mechanism of this reaction was an IgE-mediated sensitization.
format Online
Article
Text
id pubmed-3512709
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35127092012-12-21 185 Anaphylaxis after Anesthetic Reversal Chugo, Sendy World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Sugammadex is a new drug used for the reversal of neuromuscular blockade by rocuronium or vecuronium, a muscle relaxant used as fast acting. METHODS: We performed a review of a case of a patient scheduled for osteosynthesis of the ankle with a history of bronchial asthma and sensitization to Dermatophagoides pteronyssinus. After the surgery the patient suffered anaphylaxis, a minute after the use of sugammadex. RESULTS: We evaluated the drugs used during anesthesia Prick and intradermal, and we obtained positive results with Sugammadex at 1 month, 3 and 6 months. We performed the basophil activation test giving a positive result. Tests show IgE-mediated sensitization with positive skin tests and basophil activation test. CONCLUSIONS: It is believed that prior sensitization may have occurred due to ingestion of cyclodextrins which is present in many foods. The atopic status of this patient may have had some awareness of cyclodextrins. This case has been published as the first documented case of anaphylaxis by sugammadex with normal doses. Our case raises clear that the underlying mechanism of this reaction was an IgE-mediated sensitization. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512709/ http://dx.doi.org/10.1097/01.WOX.0000411942.20977.e1 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Chugo, Sendy
185 Anaphylaxis after Anesthetic Reversal
title 185 Anaphylaxis after Anesthetic Reversal
title_full 185 Anaphylaxis after Anesthetic Reversal
title_fullStr 185 Anaphylaxis after Anesthetic Reversal
title_full_unstemmed 185 Anaphylaxis after Anesthetic Reversal
title_short 185 Anaphylaxis after Anesthetic Reversal
title_sort 185 anaphylaxis after anesthetic reversal
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512709/
http://dx.doi.org/10.1097/01.WOX.0000411942.20977.e1
work_keys_str_mv AT chugosendy 185anaphylaxisafteranestheticreversal